WORLDWIDE CONTACT US ABOUT US PRODUCTS RESEARCH LICENSING NEWSROOM CAREERS INVESTORS Menu MENU THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE The rise in antimicrobial resistance has become one of the world's most pressing public health problems. Merck's long-standing commitment to the global fight against infectious disease goes hand-in-hand with a commitment to help slow the occurrence of resistance. 2 MILLION PEOPLE experience an antibiotic-resistant infection each year in the U.S. 23,000 DEATHS are caused by antibiotic resistance in the U.S. each year We’re not done yet. We need to maintain our commitment and our interest and continue to bring our full capability set to trying to do more to help solve the problem of infectious disease.” Julie L. Gerberding, M.D., M.P.H., executive vice president & chief patient officer, Merck A Message from Julie L. Gerberding, M.D., M.P.H., executive vice president & chief patient officer, Merck Here, some of Merck’s best researchers and scientists share how their work in this arena inspires them and how they are committed to the fight against antimicrobial resistance. Interested in joining our team? Start your job search! Copyright © 2009-2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map